Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Sep 30, 2022--
The "Vietnam Tuberculosis Therapeutics Market, By Disease Type (Active Tuberculosis v/s Latent Tuberculosis), By Therapy (First Line Therapy v/s Second Line Therapy), By Region, Competition Forecast & Opportunities, 2028" report has been added to ResearchAndMarkets.com's offering.
The Vietnam tuberculosis therapeutics market is anticipated to register a robust growth in the forecast period, 2023-2027. Growing demands for effective treatment and efficient pharmaceuticals to control the growing instances of tuberculosis is driving the market growth.
Besides, increasing investments and grants for tuberculosis therapeutics are boosting the growth of the Vietnam tuberculosis therapeutics market. Earlier, tuberculosis has been a leading cause of death in Vietnam. The government is aggressively implementing programs and initiatives to control the tuberculosis rates such as the National Tuberculosis Control Programme (NTP).
Rising government measures and growing public awareness of communicable illnesses are also expected to fuel the Vietnam tuberculosis therapeutics market. Rising incidences of drug susceptible tuberculosis and increase in multi-drug resistant TB cases are some of the factors boosting the market growth. Besides. More R&D efforts towards drug development, emergence of effective drug alternatives in the market, and collaborations focused on the development of shorter treatment regimens to fight resistance and address unmet medical needs, which are expected to fuel the market growth.
The Vietnam tuberculosis therapeutics market is segmented on the basis of disease type, therapy, competitive landscape, and regional distribution. Based on disease type, the market is divided between active tuberculosis and latent tuberculosis. The most common cause of tuberculosis in the general population is Mycobacterium tuberculosis.
The prevalence of Mycobacterium tuberculosis in South Asian nations like Vietnam, India, Laos, etc., is a significant contributor to the rise in tuberculosis cases and, consequently, the demand for tuberculosis medicines. Active tuberculosis patients have a propensity to spread the illness to others. Patients with latent tuberculosis, however, do not have this tendency.
Years considered for this report:
Objective of the Study:
Companies Mentioned
Report Scope:
In this report, Vietnam tuberculosis therapeutics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Vietnam Tuberculosis Therapeutics Market, By Disease Type:
Vietnam Tuberculosis Therapeutics Market, By Therapy:
Vietnam Tuberculosis therapeutics Market, By Region:
For more information about this report visit https://www.researchandmarkets.com/r/9sgnr6
View source version on businesswire.com:https://www.businesswire.com/news/home/20220930005440/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD: ASIA PACIFIC VIET NAM
INDUSTRY KEYWORD: INFECTIOUS DISEASES PHARMACEUTICAL HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 09/30/2022 10:57 AM/DISC: 09/30/2022 10:57 AM
http://www.businesswire.com/news/home/20220930005440/en